Discrimination between Alpha-Synuclein Protein Variants with a Single Nanometer-Scale Pore.

Area of Science:

• Neuroscience
• Biochemistry
• Nanotechnology

Background:

• Alpha-synuclein aggregation is implicated in neurodegenerative diseases like Parkinson's.
• Mutations and post-translational modifications alter alpha-synuclein structure and function.
• Nanopore technology offers potential for protein discrimination.

Purpose of the Study:

• To investigate if nanopore sensing can differentiate wild-type alpha-synuclein from specific variants.
• To assess the method's capability in identifying alpha-synuclein mutations and post-translational modifications.

Main Methods:

• Utilized a single nanometer-scale pore for protein analysis.
• Applied the nanopore method to discriminate between wild-type alpha-synuclein, the E46K mutant, and modified forms (nitration, phosphorylation).

Main Results:

• Successfully discriminated between wild-type alpha-synuclein and the E46K point mutation.
• Demonstrated the ability to differentiate post-translationally modified alpha-synuclein (Y39 nitration, S129 phosphorylation).
• Validated nanopore sensing as a tool for analyzing alpha-synuclein variants.

Conclusions:

• Nanopore technology provides a sensitive method for characterizing alpha-synuclein.
• This approach can identify disease-relevant alpha-synuclein alterations.
• Potential applications in diagnosing and understanding neurodegenerative diseases.